Cepham supplement for hot flashes in menopausal women
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a supplement called Cepham can help reduce hot flashes and other symptoms of menopause in women who are having severe hot flashes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 60 years old.
- You have hot flashes that are severe or very severe.
- You are not currently using hormone therapy or other medications for hot flashes.
- You do not have other serious health problems that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a natural herb called Shatavari can help with menopausal symptoms like hot flashes, sleep problems, and mood changes. It compares Shatavari to a placebo (a pill with no active ingredient) to see if it is safe and effective.
This trial tests whether a herbal supplement called Shatavari root extract can help reduce common menopause symptoms like hot flashes, night sweats, mood swings, and sleep problems in women who are in the transition to menopause.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
This trial tests if a special ashwagandha extract can help with menopause symptoms like hot flashes. It compares the extract to a placebo (a pill with no active ingredient) in women aged 40 to 55 who still have regular periods.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.
Hear when a new D008593 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.